HEALTHCARE INDUSTRY ASSOCIATION (HCIA)

RESUME BOOK
Columbia Healthcare and Pharmaceutical
Management Program

CLASS OF 2019 & 2020

 RÉSUMÉS

2019
5 LUCIE BARDET
JOSHUA BARRETT
IRINA BENIMOVICH

6 MARKENRY BENOIT
JIEXIN CAI
ALY CALLAHAN

7 VEDIKA CHAWLA
ANYA CLIFFORD
MAOR COHEN

8 ADITYA VIKRAM DAGA

DANIYAL HUSSAIN
CHRIS DENNEN 2020
9 ALEX ETTINGER 18 BEN ASCHERMAN 26 JOHN NIMMO
GAUTHIER DENOYELLE LESLYE BARTH MARGARET O’BRIEN
SARAH GHOSH ALEXANDRA CAMESAS MATTHEW PESESKY

10 GOKCE (GILLY) YILDIRIM 19 ZACK CAPLAN 27 ANDREA RADKE

SHARIFF GONNELLA RENO CHEN MODAK RAJ
PARISA HEMATI LAURENCE COMAN STEPHEN REIS

11 ANGELIKA KOROMVOKI 20 ALEX EFRON 28 ARMANDO RIVERA

JESSIE LAURASH ISAIAH EINZIG JOANNA ROBERTS
REBECCA LEVIN MICHELLE FERBER ERNIE RODRIGUEZ-DUMONT

12 SAMANTHA MARTIN 21 TESS FINKEL 29 ARIEL ROKITO

AMANDA NICKLIN LISEBETH FORBES TANYA ROSENBLUT
GUS NORTHROP BEN GUZIK STEPHANIE RUSINKIEWICZ

13 ALEXA PICCIOTTO 22 BRITTANY HAMLIN 30 SHRUTI SATISH

SOLOMON RAVICH PRATEEK HANDA DANIEL SCHWEBER
JUSTIN REGGI ALEXANDER HRYHOROWYCH VICTORIA SERRANO

14 HANNAH REITAN 23 DANIELLE LABARBIERA JENKS 31 EMILY STOOPLER

AUSTIN SHAW LIZA KIND AARTI TARKAR
CANDICE SU JAMIE LANDSMAN IGNACIO THOMSON

15 RON TAITZ 24 CHLOE LI 32 AMY WOODRUFF

ANAND TAMIRISA ERIK MAI MINGMING WU
NAOMI TUDHOPE KUNAL MALHOTRA LU YE

16 SHIRLEY WANG 25 EMMA MCGREGOR 33 CARLOS ZARAZUA

SHERIE ZHOU ANISHA MUKHERJEE JOSHUA ZENILMAN
ZAID MUSTAFA TIFFANY ZHAO

2 2019-2020 HCIA RÉSUMÉ BOOK

HCIA AT
COLUMBIA BUSINESS SCHOOL
The Healthcare Industry Association (HCIA) is committed to expanding opportunities
outside of the classroom for Columbia Business School students to learn about the many
segments of the healthcare industry. Working in close collaboration with the Healthcare and
Pharmaceutical Management Program, HCIA organizes a variety of activities throughout
the year. It offers members the opportunity to increase their knowledge of the healthcare
industry, expand their professional networks, learn about diverse career paths, and secure
internships, full-time opportunities, and in-semester projects.
The healthcare-related activities broaden students’ exposure to global healthcare practice
and complement the learning that occurs in the classroom. Students interact regularly with
leading industry practitioners, many of whom are alumni, through experiential learning
opportunities and programming. The following events are offered throughout the year:
n Columbia Business School Annual Healthcare Conference
n Healthcare Career Panel
n “Day in the Life” Events with select corporate partners
n Lunch and Learn Networking Events
n Alumni Networking Events
n Executive Speakers
n Treks and NYC Site Visits
HCIA members accept full-time and internship positions across the spectrum of the
healthcare industry. Many students are recruited into management development rotation
programs and functional positions (finance, marketing, business development, strategic
planning, etc.) at global healthcare enterprises and early-stage life sciences and healthcare
services companies. Students also obtain healthcare-focused positions in consulting,
investment banking, private equity/venture capital, and nonprofit organizations.
More information can be found on our website http://www.columbiahcia.com

3
 HEALTHCARE AND PHARMACEUTICAL
MANAGEMENT PROGRAM
Columbia Business School’s Healthcare and Pharmaceutical Management (HPM) Program
provides students with a real-world understanding of the increasingly complex healthcare
environment. Through a multidisciplinary approach shaped by innovative course offerings,
complementary out-of-class activities, networking opportunities with industry leaders, and one-
on-one career planning/mentoring, the Program offers a dynamic learning experience focused
on the major issues affecting the global healthcare ecosystem. The HPM Program emphasizes
critical thinking and encourages the development of new approaches to address the strategic,
economic, competitive, technological, and sociopolitical challenges facing this important sector.
Healthcare courses are offered as electives (no minimum requirements) within the overall
curriculum at Columbia Business School, enabling students to tailor their coursework to their
individual needs and career aspirations.
The HPM Program offers students:
n A flexible, comprehensive, and pragmatic array of healthcare courses
n A career-focused approach to learning and professional development
n A powerful network of alumni and other healthcare business professionals
n A global perspective
n An entrepreneurial mindset
n An attractive New York City location
n Access to the world-class Columbia healthcare community
The HPM Program was established in 2006. It is currently led by Bunny Ellerin, who brings over
20 years of leadership experience in healthcare to Columbia Business School. Bunny’s diversity
of experience includes healthcare delivery, life sciences (pharma and medtech) and digital
health, giving her a broad-based knowledge of the entire ecosystem. The Program itself was
designed by seasoned industry executives who understand first-hand the skills and industry
insight necessary to be successful in this dynamic and highly challenged global business sector.
Healthcare electives build on the MBA Program’s rigorous core-curriculum and are designed
and taught by a unique mix of experienced industry executives and prominent CBS faculty.
They cover each major healthcare sector (biopharmaceuticals, medical devices and diagnostics,
healthcare services, and healthcare information technology) on a global basis, from both
industry and investor perspectives. Additionally, all functional areas are covered: strategy,
management, marketing, finance, business development, M&A, risk management, operations,
and policy.
The Program helps students successfully pursue careers in pharmaceuticals, biotechnology,
medical devices & diagnostics, healthcare services/HCIT, management consulting, investment
banking, equity research, venture capital, private equity, and entrepreneurship.
Information on the HPM Program can be found at: www8.gsb.columbia.edu/healthcare/

4 2019-2020 HCIA RÉSUMÉ BOOK

2019 : Bardet - Benimovich
LUCIE BARDET
lbardet19@exch.gsb.columbia.edu
Venture Capital and Entrepreneurship
Haas School of Business
Berkeley, CA
MBA, 2019
Ecole de Biologie Industrielle
Cergy, France
MSE, Master of Biotech Engineering, 2010
GLOBAL NEUROHEALTH VENTURES,
San Francisco, CA
Investor Intern
2018 – Present
Raising firm’s $120M fund to LPs
worldwide. Creating templates catalogue
(contracts, contents, …).
BEE PARTNERS, San Francisco, CA
VC Associate Intern
2018
Screened 500+ proposals, did due
diligence and prepared term sheets and
investment memos. Authored white paper
and compensations analysis.
MORIMATSU PHARMACEUTICALS,
Shanghai, China
Validation and Quality Manager
2014 – 2017
Strategic consulting to biopharma leaders
building multi-million-dollar facilities. Led
interdisciplinary Chinese team of 20+.
clients included Unilever in South Africa
and Novartis in Singapore.
BIOMERIEUX SHANGHAI BIOTECH,
Shanghai, China
Project Manager
2012 – 2014
Supervised team of 10+ to quadruple
production capacity.
NOVO NORDISK ENGINEERING –
PHARMAPLAN, Lyon, France
Process Engineer
2011 – 2012
Conducted $24M compliance upgrade
project for Ipsen in France.
JOSHUA BARRETT
jbarrett19@gsb.columbia.edu
Consulting and Private Equity
Georgetown University School of Medicine
Washington, DC
MD, 2021
Yale University
New Haven, CT
BS, Molecular Cellular Developmental
Biology, 2015
WEILL CORNELL MEDICINE, New York, NY
Quality & Patient Safety Internship
2018
Developed and implemented institutional
opioid prescribing policy and pain
management strategy for 1,900 clinicians.
Published opioid report, resource toolkit,
checklist, and patient brochures to change
physician opioid prescribing behavior.
CENTIVO HEALTH, New York, NY
MBA Internship
2018
Collaborated with founding team to
perform research and analysis to inform
provider network strategy.
Analyzed provider data to prioritize
national provider partners, assess
coverage, and identify clients.
IRVING INSTITUTE FOR CLINICAL
RESEARCH, New York, NY
MBA Researcher
2017 – Present
Published journal article as lead author
in Health Affairs on value-based payment
programs to treat opioid addiction.
Spearhead Commonwealth Fund
publication investigating behavioral health
integration in primary care practices.
IRINA BENIMOVICH
ibenimovich19@gsb.columbia.edu
Venture Capital and Private Equity
New York University
New York, NY
MS, 2011
ING CAPITAL, New York, NY
Senior Associate, Leverage Finance
2018
Originate and execute leveraged finance
transactions for a $1.4B portfolio with 37
companies in the Healthcare Services and
Medical Device space.
Prepare and deliver marketing pitches,
credit analysis, including financial
modeling, due diligence and discussions
with legal counsel on transaction
documentation.
CRÉDIT AGRICOLE, New York, NY
Senior Associate, Structured Finance
2014 – 2017
Built and supported sustainable client
relationships for a $14B portfolio.
Relationship manager that contributed to
deal origination, live deal execution, and
financial due diligence.
Proposed and negotiated Term Sheets for
new transactions.
SUMITOMO MITSUI BANKING
CORPORATION, New York, NY
Associate, Project Finance
2011 – 2014
Maintained a portfolio for closed
transactions including amendments,
administration and periodic credit reviews.
5
2019 : Benoit - Cohen
MARKENRY BENOIT
mbenoit19@gsb.columbia.edu
Management
The Pennsylvania State University
University Park, PA
BS, Microbiology, 2012
BRISTOL-MYERS SQUIBB, Princeton, NJ
MBA Summer Intern –
R&D Strategy & Planning
2018
Co-piloted a survey issued to over 580
senior leaders across R&D, HR, IT, and
Finance to examine individual networks
as part of an organization-wide network
analysis.
Leveraged IT usage data in conjunction
with network analysis results to identify
silos between R&D business units from a
technological and cultural perspective and
recommend both quick-win opportunities
and long-term solutions.
ING CAPITAL LLC, New York, NY
Intern, Analyst, Associate
2013 – 2017
Managed portfolio by forecasting draws
upon and repayments of portfolio loans
for budgeting purposes (working directly
under Infrastructure Finance team head).
Discussed with senior credit officers
various requests from clients to waive or
amend financing documentation, including
analyses on perceived risks associated
with clients’ proposals.
Constructed financial models/analyses,
and presentation materials jointly with a
VP-level team member for advisory work.
6 2018-2019 HCIA RÉSUMÉ BOOK
JIEXIN CAI
jcai19@gsb.columbia.edu
Venture Capital and Management
Fudan University
Shanghai, China
BA, English and Accounting, 2010
MORNINGSIDE VENTURES,
Shanghai, China
Healthcare Investment Intern
2017
Conducted due diligence, deal sourcing
and competitive analysis for portfolio
companies.
ABBOTT LABORATORIES, Shanghai, China
Associate Product Manager
2015 – 2017
Increased sales growth of promotional
product by 69% by adjusting distribution
channel promotion after market analysis.
Initiated social media marketing project
and achieved goal of 1000 registrations
six months ahead of schedule with 50%
allocated budget, championing Best Digital
Program in Global Marketing Olympics.
BOSTON SCIENTIFIC, Shanghai, China
Senior Professional Education Specialist
2013 – 2015
Spearheaded overseas doctor education
programs by establishing SOP and
collaboration with 12 host institutions.
Conducted 15 domestic doctor education
programs covering 550+ doctors, advancing
clients’ concepts and skills - product usage
increased by 12 times in one case.
MEDTRONIC, Shanghai, China
Clinical Specialist / Business Trainee
2010 – 2013
Performed analytical troubleshooting and
patient treatment consultation through
technical support in catheter labs &
8,000+ patient follow-ups.
Built patient referral fast track from
hospital unqualified to implant devices to
qualified ones, breaking regulatory barriers
for unqualified hospitals to enter market.
ALY CALLAHAN
acallahan19@gsb.columbia.edu
Strategy and Entrepreneurship
Lehigh University
Bethlehem, PA
BS, Bioengineering, 2011
TRUVERIS, New York, NY
MBA Intern, Product Management
2018
Led revamp of client-facing reporting
platform; reduced annual spend by 50%
($600K) and opened new revenue streams.
Bridged cross-functional stakeholders
from product, engineering, account
management, and analytics to get buy-in
on vision.
Made business case to license business
intelligence software after conducting
structured vendor evaluation, including
prototyping new platform in two tools and
testing hypotheses via user research.
ATHENAHEALTH, Watertown, MA
Product Manager, Analytics
2013 – 2017
Led nine-person team of local and remote
engineers, user experience, and product
associates creating new dashboard
application to enable customers to
monitor business performance; met alpha
goals, moving to 250-customer beta.
Partnered with VP of division to define
five-year vision and strategic execution
plan to productize company’s data asset.
Ran team using strategic analytics to
optimize business performance for a
portfolio of national hospital clients; saved
largest U.S. nonprofit health system $45M.
IQVIA, Waltham, MA
Market Research Analyst, Diagnostics
2011 – 2012
Produced competitive analyses, financial
models, strategic appraisals, product
reviews, and market outlooks.
VEDIKA CHAWLA
vchawla19@gsb.columbia.edu
Marketing and Strategy
Brown University
Providence, RI
BSc, Biomedical Engineering, 2013
NOVARTIS PHARMACEUTICALS,
East Hanover, NJ
MBA Intern – US Oncology
2018
Led the design and development of a sales
tool for the Neuroendocrine Tumors (NET)
franchise to assist 63 field representatives
in account planning and call preparation.
Collaborated with agency partners to
develop an innovative simulation exercise
on account-targeting for annual sales
meeting.
DELOITTE CONSULTING, Houston, TX
Consultant
2015 – 2017
Led a software upgrade for the emergency
room application of a major health system
client in three geographic locations.
Configured setup for electronic submission
of a provider’s quality data to comply with
a federal mandate and avoid ~$10M in 2018
Medicare fee penalties.
Spearheaded the firm’s inclusion initiative
for 55 clinical information systems analysts.
DELOITTE CONSULTING, Bangalore, India
Business Technology Analyst
2013 – 2015
Implemented new functionality in
electronic health records of organizations
to streamline patient care and integrate
with third-party applications.
Designed a new template for software
change control, which was adopted by the
client for use by a team of 200+ analysts.
ANYA CLIFFORD
aclifford19@gsb.columbia.edu
Strategy and Management
Wellesley College
Wellesley, MA
BA, Bioethics, 2012
GILEAD SCIENCES, San Francisco, CA
MBA Intern, Managed Markets Strategy
and Operations
2018
Informed market access strategy by
developing the first enterprise-wide
financial baseline and projections for
patient support programs, mapping annual
costs against internal supply-chain and
sales data.
Achieved buy-in from finance, brand, and
patient operations teams to implement
recommendations after presenting analysis
to senior leadership.
ROIVANT SCIENCES, New York, NY
MBA Intern, Business Operations
2018
Developed the business case for social
listening tools during clinical trial patient
recruitment and analyzed target company
for acquisition.
SPREZZATURA MANAGEMENT
CONSULTING, Washington, DC
Consultant
2015 – 2017
Implemented a Congressionally-mandated
health IT modernization initiative for
Department of Veterans Affairs (VA) client,
by managing health product development
and support teams through software
rollout.
Identified and reduced financial waste by
10% for client organization’s $40M budget
by creating data models to analyze client’s
current vs expected personnel/software
costs and informing new contracting
strategy.
MAOR COHEN
mcohen19@gsb.columbia.edu
Technology and Entrepreneurship
University of Michigan
Ann Arbor, Michigan
BA, Organizational Studies
(Concentration: Behavioral Economics),
2012
CAREDOX, New York, NY
Summer Operations Intern
2018
Created nationally scalable processes and
outsourcing strategy for delivering health
services to public schools.
Designed a community-based chronic
care management program for Medicaid
beneficiaries.
ADVISORY BOARD COMPANY,
Washington, DC
Senior Dedicated Analyst
2015 – 2017
Developed initiatives to improve
organizational culture for health system
clients, executing surveys and presenting
recommendations to senior executives.
Taught leadership skills to groups of up to
200 frontline managers.
Senior Analyst
2014 – 2015
Launched digital learning product used by
20,000 people across 200 organizations.
Won firm’s top prize for excellence in
product and design after developing
an educational mobile app in company
hackathon with 15 other teams.
Analyst
2012 – 2014
Built curriculum delivered to 2,500
high-potential executives across different
sectors of healthcare.
Conducted primary and secondary
research, created course materials, trained
faculty, and planned multiday conferences.
7
2019 : Daga - Ghosh
ADITYA VIKRAM DAGA
avd2128@gsb.columbia.edu
Finance
University of Kolkata
India
Bachelor of Commerce, 2000
Institute of Chartered Accountants India
Chartered Accountant, 2002
THERMO FISHER SCIENTIFIC, Boston, MA
Senior Director Finance
2018
Planning, Analytics and Reporting
PHILIPS LIGHTING, Somerset, NJ
Director Finance
2013 – 2018
Managed planning & performance cadence
for Lighting America’s P&L (Sales $1.8B)
with 92% forecast accuracy.
Turned around declining Luminaire
business to +2% growth.
PHILIPS HEALTHCARE, Boston, MA
Finance Business Partner
2011 – 2013
Defined finance governance, control and
reporting framework for expansion in
Japan, UK, and Netherlands.
Identified and drove targeted acquisition
process.
PHILIPS MRI INVIVO, Gainesville, FL
Financial Controller
2009 – 2011
Executed post-acquisition integration while
turning-around business exceeding ‘Value
Creation’ targets.
PHILIPS, Netherlands and India
Various Finance Roles
2002 – 2008
Internal Audit - planned, organized,
executed audit assignments globally.
Finance Shared Center (FSC) - supported
designing, building & testing, implementing
and roll out of the captive FSC.
8 2019-2020 HCIA RÉSUMÉ BOOK
DANIYAL HUSSAIN CHRIS DENNEN
dhussain19@gsb.columbia.edu cdennen19@gsb.columbia.edu
Venture Capital, Private Equity/Investing Private Equity, Venture Capital,
Entrepreneurship, Strategy
Columbia University
New York, NY Yale University
MPH, 2015 New Haven, CT
BA History, 2012
University of Pennsylvania
Philadelphia, PA HEALTH ENTERPRISE PARTNERS (HEP)
BSc, Chemical & Biomolecular MBA Intern
Engineering, 2009 2017 – 2018
BA, Economics, 2009
Led projects in all phases of deal life-
FLAGSHIP PIONEERING/COGEN, cycle including: sourcing, diligence, deal
Cambridge, MBA execution, liquidation, and portfolio
Summer Associate, 2018 company and investor relations.
Scientific evaluation of novel therapeutic Constructed financial model and returns
target from literature. projections for both growth equity deals
Led indication prioritization exercise for (Series A-D) and leveraged buyouts.
initial produce development.
STRATEGY&, New York, NY
Analyzed key clinical development
Manager
trends and proposed biomarker based
2012 – 2017
development strategy.
Advisory Manager within the Heath
ASTRAZENECA, Gaithersburg, MD Industries Group in the Management
Associate Director - ImmunoOncology Consulting practice; helped 20+ clients
2016 – 2017 navigate and succeed within the changing
Led forecasting process and customized and challenging healthcare landscape.
market research to identify drivers for
Advised clients across the healthcare
Bladder and Head & Neck cancer drugs.
industry. Client list includes: large national
Conducted commercial assessments to payers, large scale provider organizations,
guide strategic investment decisions across cancer hospitals, academic medical
various solid tumors. centers, digital health companies.
Implemented a >$1M process for tracking
Promoted to Manager in four years, the
drug performance.
quickest to do so in PwC Advisory.
HURON CONSULTING, New York, NY
Manager, 2014 – 2016
Led engagements across life-science
clients spanning the entire clinical
development spectrum.
Developed detailed business cases around
acquisition targets.
FRANKEL GROUP, New York, NY
Consultant
2009 – 2013
Developed commercialization, business
development, pricing & life cycle
strategies.
ALEX ETTINGER
aettinger19@gsb.columbia.edu
Management and Strategy
University of Pennsylvania
Philadelphia, PA
BSE, Bioengineering, 2012
PFIZER INC, New York, NY
Marketing Summer Associate, 2018
Identified opportunities and
recommended strategies to grow
CHANTIX® revenue in over 300 hospital
systems.
Created six marketing pieces to drive
HCP awareness of revised Department of
Transportation policy.
JDS THERAPEUTICS, Purchase, NY
Brand Manager, 2015 – 2017
Assistant Brand Manager, 2014 – 2015
Led cross-functional Product Development
Team to guide new product investments
based on market research, regulatory
pathway evaluation, supply chain and
manufacturing, and IP analysis.
Directed marketing activities for products
RELIZEN® and SERENOLTM®, resulting in
141% increase in sales from previous year.
Coordinated and executed launch of
SERENOLTM® and correspondingly
collaborated with Executive Team to
implement go-to market strategy for
national sales force.
SIMON-KUCHER & PARTNERS, New York, NY
Consultant, 2012 – 2014
Delivered actionable recommendations to
six of the top ten global pharmaceutical
companies across variety of indications
including: oncology, neurology,
interventional cardiology, and
endocrinology.
Created comprehensive commercial
readiness program for a global
pharmaceutical company’s lead ovarian
cancer compound by conducting robust
primary research across the US, EU-5, and
Japan.
GAUTHIER DENOYELLE
gdenoyelle19@gsb.columbia.edu
Strategy and Data Analytics
Ecole Centrale Paris
Châtenay-Malabry, France
BS, MSc, Industrial Engineering, Chemistry,
2013
ROLAND BERGER,
Paris, France and Milan, Italy
Senior Consultant
2013 – 2017
Worked on 25+ strategic (due diligence,
business review & planning) and
operational projects (supply chain
optimization, procurement transformation,
cost reduction), of which 60-70% were in
Healthcare and Life Sciences.
APPLE, Paris, France
Data Science Intern
2012
Administered geo-marketing statistical
analyses and opportunity assessment
studies to support Apple retail network
development.
STANFORD UNIVERSITY, Palo Alto, CA
Visiting Researcher – ZareLab
2011
Performed research focused on controlled
release of mRNA from PLGA nanoparticles
for gene therapy delivery.
SARAH GHOSH
saghosh19@gsb.columbia.edu
Med Tech, Pharmaceuticals and Biotech,
Venture Capital
University of Chicago
Chicago, Illinois
AB, 2011
TRUVERIS, New York, NY
Manager of Patient Access, Life Sciences
2018
Developed innovative patient copay
benefit design for a cardiovascular drug
utilizing in-house pharmacy technology and
data analytics.
Advised pharmaceutical clients on drug
pricing and yearly planning.
Led the business and technology
development of a pilot program for an
ophthalmologic implant’s patient access
program, growing program revenue 200%
and managing 700+ physician offices.
HAVAS HEALTH, New York, NY
Director of Strategy
2016
Served as marketing and strategic advisor
to Top 5 Pharmaceutical Company’s
Oncology brands.
Designed multiple competitive planning
workshops for Oncology clients in
preparation for 2016 and 2017 American
Society of Clinical Oncology Conferences.
Analyzed Phase II and III oncology clinical
trial data to determine competitive
advantages and develop pre and post-
launch plans.
STRATEGY&, New York, NY
Senior Consultant, Pharma/Life Sciences
Commercial Strategy
2011
Developed 3-year U.S. prelaunch plan for
Top 5 Pharma client’s biosimilar infliximab.
Executed a “beyond-the-pill” service
expansion plan for Top 5 Pharma’s in-house
specialty pharmacy.
9
2019 : Yildirim - Levin
GOKCE (GILLY) YILDIRIM
gyildirim19@gsb.columbia.edu
Entrepreneurship and Strategy
Columbia University
New York, NY
MSc, Biomedical Engineering, 2004
New Jersey Institute of Technology
Newark, NJ
BSc, Industrial Engineering, 2003
STRYKER, Mahwah, NJ
Senior Staff Development Engineer
2013
Generated big-data analytics models for
human bone density assessment in robotic
surgery resulting in multiple patents.
Generated business strategy reports for
implant product portfolio.
PIPELINE, Cedar Knolls, NJ
Senior Research Engineer
2011 - 2013
Tested and cleared implantable medical
devices through the FDA.
Designed and tested early concept robotic
surgery implants using titanium additive
manufacturing resulting in multiple
patents.
NYU LANGONE MEDICAL, New York, NY
Research Engineer
2004 - 2011
Partnered with surgeons and medical
device manufacturers for implant concept
design tests.
Designed test machinery for orthopaedic
implant testing.
10 2019-2020 HCIA RÉSUMÉ BOOK
SHARIFF GONNELLA
sgonnella19@gsb.columbia.edu
Management and Strategy
Embry-Riddle Aeronautical University
Daytona Beach, Florida
MS, Safety Systems and Management, 2004
BS, Business Administration in Aviation, 2002
CARGOLUX AIRLINES, Houston, TX
Central/South America Business
Development Manager
2018 – Present
Route Manager – The Americas
2015 – 2018
North America
Business Development Manager
2014 – 2015
Led all sales and marketing activities,
strategy formulation, business
development, legal, and operational
overview of the region.
Hold full P&L responsibility for sales
& operations through direct training,
leadership, and supervision of the 6
independent General Sales Agents
organizations comprised of 15 sales
representatives across LATAM territory.
Represent the company views at
negotiations as a member of government
delegations.
LATIN LINK LOGISTICS LLC, Miami, FL
Co-Founder & Managing Director
2011 – 2014
Founded a Freight forwarder / NVOCC
(full-scale operational set-up). Carried out
full-scope responsibility for operations,
financial management, policies,
procedures, strategic planning, technology,
and sales/marketing.
Managed all sales activities and was in
charge of increasing performance through
creative and selective service capabilities
to become a significant player in the Latin
America logistic.
PARISA HEMATI
phemati19@gsb.columbia.edu
Precision Medicine and Genomics Testing
Sarah Lawrence College
New York, NY
MS, Human Genetics, 2015
University of British Columbia
Vancouver, BC
BS, 2013
INSTITUTE FOR GENOMIC MEDICINE,
COLUMBIA UNIVERSITY, New York, NY
Genetic Counselor
2017
Led global project focused on gene
discovery, resulted in collaboration with
more than 15 medical institutions.
Managed referrals to diagnostic
sequencing research study by reviewing
medical records, interviewing candidates,
and determining eligibility, resulted in
enrolling more than 100 families into
studies in the new research institution.
Analyzed identified genetic variants to
determine pathogenicity by conducting
extensive scientific research, researched
more than 500 genes.
Ran monthly meetings with leadership
team to present recommended diagnosis
for each patient based on my research,
resulted in diagnosis for more than 50
patients.
ANGELIKA KOROMVOKI
akoromvoki19@gsb.columbia.edu
Entrepreneurship and Private Equity
King’s College London
London UK
BSc, Business Management, 2013
PHARMATHEN S.A., Athens, Greece
Business Development Manager
2014 – 2017
Responsible for out-licensing the
company’s dossiers of generic molecules in
a number of European countries.
Developed and executed commercial
strategy for countries of responsibility.
PHARMATHEN Hellas, Athens, Greece
Product Manager for NUXE cosmetics
2013 – 2014
Developed and executed marketing
strategy of NUXE Greece.
Designed, implemented, and analyzed
promotional campaigns for existing
products and led new product launches.
JESSIE LAURASH
jlaurash19@gsb.columbia.edu
Private Equity and Venture Capital
Georgetown University
Washington, DC
BS, Biology, 2011
HEALTH ENTERPRISE PARTNERS,
New York, NY
MBA Intern
2017 – Present
Evaluate investment opportunities,
conduct financial, market, and
company due diligence, model returns
scenarios, and communicate investment
recommendations.
Produced strategic growth assessment and
identified go-to-market opportunities for
portfolio company.
MEDIQUIRE, New York, NY
Director of Operations
2016 – 2017
Developed and managed initial operating
model and company-wide key performance
indicators across all functional teams.
Managed product delivery and
implementation for all health center
clients.
EVOLENT HEALTH, Arlington, VA
Associate Director
2014 – 2016
Identified and analyzed opportunities to
partner with leading health systems to
support their value-based care businesses.
Developed business plans for Medicaid
and Practice Optimization technology and
service offerings.
BOOZ ALLEN HAMILTON, Washington, DC
Senior Consultant
2011 – 2014
Provided project management support
to the Department of Health and Human
Services and its implementation of the
health insurance exchange program.
REBECCA LEVIN
rlevin19@gsb.columbia.edu
Consulting and Management
Columbia Business School
Columbia Mailman School of Public Health
New York, NY
MBA/MPH, 2020
COREPOWER YOGA, Denver, CO
Chief of Staff to CEO and CFO
2015 – 2017
Led overhaul of annual liability insurance
renewal process by organizing cross-
functional team to budget accurate
construction costs, studio-level
performance, and SG&A leading to
accurate forecasting via systematic
reporting mechanism.
Streamlined studio supply ordering by
analyzing order history and standardizing
order process through collaboration with
studio management.
Developed customer incident dashboard
for studio management with an automatic
decision tree that initiated remedial
actions and consolidated incident trends
to inform policy changes.
O2 ASPEN, Aspen, CO
Account Manager,
Retail Accounts and Yoga Membership
2013 – 2014
Increased client retention by instituting
customer and staff feedback channels and
analyzing seasonal purchasing history
ASPEN VALLEY FOUNDATION, Aspen, CO
Program Assistant
2012 – 2013
Implemented new community-facilitated
Suicide Prevention Training that has since
grown to multiple counties and trains
1,000+ community members annually.
11
2019 : Martin - Reggi
SAMANTHA MARTIN
smartin19@gsb.columbia.edu
Private Equity and Real Estate
Georgetown University
Washington, DC
BS, Human Science, 2013
PFIZER, INC., New York, NY
MBA Summer Associate
2018
Developed go-to-market strategy for new
Pfizer Direct home delivery e-commerce
platform, determining key performance
indicators, expanding product offerings,
and forecasting $10M in incremental
revenue.
Identified optimally balanced channel mix
for targeted marketing to effectively reach
key provider and patient populations.
SUPPORTIV, INC., New York, NY
MBA Product Strategy Intern
Conducted pre-launch market
research to develop go-to-market and
commercialization strategies.
Projected market demand and forecasted
revenue estimates based on proposed
pricing methodologies.
DELOITTE LLP, New York, NY
Consultant, US Strategy
2015 – 2017
Business Analyst, US Strategy
2013 – 2017
Developed future revenue opportunity
model to estimate clients’ professional
services spend, identified $300M
incremental opportunity across Deloitte’s
core and adjacent markets.
Partnered with data analytics start-ups to
build cognitive technology-powered risk
assessment platform for financial services
clients, developed use cases for testing
hypotheses on novel datasets.
Created business cases recommending
$10M+ investments in Life Sciences
practice, resulting in 30% increase of
projected annual revenues by 2020.
12 2019-2020 HCIA RÉSUMÉ BOOK
AMANDA NICKLIN
anicklin19@gsb.columbia.edu
Marketing, Management
Cornell University College
of Veterinary Medicine, Ithaca, NY
DVM, 2014
Rensselaer Polytechnic Institute
Troy, NY
BS, Biology, 2010
CELGENE, Summit, NJ
MBA Summer Intern
2018
Led brand-wide, cross-functional
brainstorming workshop to develop
positioning of initiation support services
& presented recommendations to senior
leadership.
Engaged with colleagues, vendors, and
external technology firms to develop
implementation strategy for technology
solution.
ANIMAL EYE GUYS, Fort Lauderdale, FL
Ophthalmology Specialty Intern
2015 – 2016
Examined and developed appropriate
diagnostic and therapeutic plan for
approximately 30 patients per day.
Led revision of medical templates
to increase doctor efficiency and
comprehensiveness of medical records.
ANIMAL MEDICAL CENTER, New York, NY
Small Animal Medicine
and Surgery Rotating Intern
2014 – 2015
Prioritized care of most critically ill
patients and delegated treatments to
facilitate rapid flow through emergency
room.
Collaborated with and presented cases to
more than 60 board-certified specialists
and residents in care of hospitalized
patients.
GUS NORTHROP
anorthrop19@gsb.columbia.edu
Pharmaceutical & Biotech LDPs,
Marketing and New Product Planning
Oxford University
Oxford, UK
BA Medical Sciences, 2011
BIOMARIN, San Francisco, CA
Pipeline Commercialization MBA Intern
2018
Market planning and pipeline marketing for
Phase 3 Hemophilia A gene therapy.
Managed planning and execution of KOL
and Patient Advocate Advisory Board (>20
attendees).
Analyzed patient survey data to segment
and profile early adopters.
GLOBE LIFE SCIENCES, London, UK
Consultant, 2017
Promotion to most senior non-partner
grade before MBA.
Senior Analyst, 2014 – 2017
Led ‘war-gaming’ workshop with cross-
functional executives at top 10 pharma to
modify $370M brand’s strategy prior to
competitor launch (annualization of this
exercise).
Modeled biotech’s pipeline ($500M rNPV),
with valuation underpinning 3 pharma
collaborations ($200M upfront, >$5B
potential milestones).
Business Analyst, 2013 – 2014
Designed and delivered quarterly
competitive intelligence reports for $750M
franchise at top 10 pharma, leading to
project renewal and top consultancy
ranking in 2014.
Completed market and product
assessment of biotech’s lead Phase II
program, with forecast underpinning
negotiations in $650M pharma acquisition
($200M upfront).
Research Analyst, 2012 – 2013
Fast-track promotion to Business Analyst
(<1 year).
ALEXA PICCIOTTO
apicciotto19@gsb.columbia.edu
Healthcare, Strategy and Operations
Columbia Business School & Mailman School
of Public Health, New York, NY
MBA & MPH, 2019
University of Maryland
College Park, MD
BS, Marketing 2013
MEMORIAL SLOAN KETTERING CANCER
CENTER, New York, NY
MBA Intern, Operations Strategy
2018
Managed the evaluation of pharmacy
supply chain to streamline purchasing
approvals, assess demand, and improve
vendor contract terms.
Analyzed patient discharge data and
observed hospital floor workflows to
implement improvements to reduce
discharge time by 9.7%.
MONTEFIORE HEALTH SYSTEM,
New York, NY
MBA Intern, Strategic Planning
2018
Helped build service line strategies for
obstetrics department.
Developed market assessments to
determine strategic opportunities for
clinical expansion.
MINDSHARE, New York, NY
Manager, Media Strategy
2017
Managed $30M+ media campaigns for
Unilever and American Express clients.
Prepared a weekly competitive landscape
update of the haircare category for
Unilever clients that informed media
strategies.
SOLOMON RAVICH
sravich19@gsb.columbia.edu
Management Consulting
University of Michigan -
Ross School of Business, Ann Arbor, MI
BBA, Strategy, 2012
THE BOSTON CONSULTING GROUP
(BCG), New York, NY
Consultant
2018
Developed best-in-class guidelines for
regulatory change controls and regulatory
implementation with local health-
authorities as part of integration of $17B
pharmaceutical with global distribution of
sterile injectables.
GOLDMAN SACHS, New York, NY
Management & Client Strategy
2014 – 2017
Designed and led market share growth
initiative across 500+ sales members,
conducting competitive analysis and client
segmentation to identify potential revenue
of $150M+ over three years.
Led team of six across Sales, Legal, and
Technology to design commercialization
strategy, resulting in $3m+ revenue growth.
Conducted study of 25+ investment firms
to develop accountability framework to
respond to client feedback, generating
$2m+ growth in sales revenue.
ADVISORY&, New York, NY
Senior Associate Consultant
2012 – 2014
Directed team of three consultants and six
developers as project testing lead for sales
and trading software, resulting in improved
throughput rates.
Trained 30+ clients on IT procedures,
leveraging client insights and industry
leading metrics to strengthen cyber
security, resulting in cost savings of $10m.
Awarded “Rookie of the Year” honors for
outstanding client service.
JUSTIN REGGI
jreggi19@gsb.columbia.edu
Technology and Strategy
University of Pennsylvania
Philadelphia, PA
BA, Biological Basis of Behavior, 2012
MOUNT SINAI’S LAB100, New York, NY
In-Semester Fellow
Fall 2018
Developing strategic partnership and
monetization strategy for Mount Sinai’s
Lab100, a hybrid clinic and lab that
leverages technology and data to redesign
ways to measure health and deliver care.
MEDIDATA SOLUTIONS, New York, NY
Product Marketing MBA Intern
Summer 2018
Collaborated across marketing, product,
and sales teams to develop marketing plan
and GTM assets for new data analysis and
professional services offering and increase
CLV of software-only customers.
Created customer segmentation
framework to prioritize highest
opportunity targets and translated
customer behavior into data-driven digital
marketing campaign.
BLUEPRINT RESEARCH GROUP,
New York, NY
Senior Consultant
2012 – 2017
Managed client relationships and led
insight development for product launch
and marketing strategy projects for life
sciences companies including Roche/
Genentech, Amgen, AstraZeneca, and
Allergan.
Opened London office with Associate
Partner, winning and managing $8M in EU-
based project work in 2016-2017.
Founded pro bono arm of company by
spearheading partnership with non-profit
organization Solving Kids’ Cancer.
13
2019 : Reitan - Tudhope
HANNAH REITAN
hreitan19@gsb.columbia.edu
Marketing and Strategy
University of Michigan
Ann Arbor, MI
BA, History and International Studies, 2013
PFIZER INC, New York, NY
Summer Associate, Marketing
2018
Applied behavioral economic concepts
and market research findings to enhance
key consumer marketing tactic for vaccine
adherence.
Conducted market research with 250+
parents to test new creative concepts for
vaccination reminder postcards.
DELOITTE CONSULTING, Chicago, IL
Consultant, 2016 – 2017
Business Analyst, 2014 – 2016
Created strategic vision for Fortune
100 pharmaceutical company’s contract
manufacturing business; interviewed
executives, launched and analyzed
employee survey, and presented findings
to senior leadership.
Managed design of global operating
model for $500M joint venture between
Fortune 500 medical device company and
private equity firm; worked with VP-level
clients in finance and supply chain to build
operational process flows, draft contracts,
and prepare staff for organizational
changes.
Analyzed customer data sets for medical
device company’s $24M product line
integration; built model to monitor sales
and prioritized field force outreach to help
client exceed goal of retaining 70% of pre-
acquisition revenue.
Led trainings for nine functional
departments and conducted vendor
coordination for launch of software
product to streamline management of
$100M in accounts receivable for regional
hospital system.
14 2019-2020 HCIA RÉSUMÉ BOOK
AUSTIN SHAW
ashaw19@gsb.columbia.edu
Strategy and Management
Columbia Mailman School of Public Health
New York, New York
MPH, 2019
University of North Carolina at Chapel Hill
Chapel Hill, NC
BA, Economics, 2013
HOSPITAL FOR SPECIAL SURGERY,
New York, NY
Pre-MBA Strategy Intern
2013
JOHNSON & JOHNSON
Medical Device Marketing MBA
Summer Associate
2018
Developed a marketing strategy refresh for
a $50M medical device within the Ethicon
Biosurgery product suite.
HOSPITAL FOR SPECIAL SURGERY,
New York, NY
Pre-MBA Strategy Intern
2013
Developed dynamic dashboards for
C-Suite to analyze regional markets,
patient geography, and competitive market
share.
DELOITTE CONSULTING, McLean, VA
Consultant, Strategy & Operations
2015 – 2017
Worked across provider space to conduct
outpatient and competitive analysis and
build financial models for C-suite clients to
monitor implementation of newly adopted
strategic initiatives.
Led teams of data scientists, designers,
and developers to apply design thinking
and transform big data into user-friendly
prototypes for multiple clients through a
Deloitte Analytics Fellowship.
Established global reporting processes to
track execution of new finance activities
across all locations globally for two major
pharmaceutical companies.
CANDICE SU
csu19@gsb.columbia.edu
Corporate Finance and Operation
Columbia Business School
New York
MBA, 2019
MERCK & Co., Kenilworth, NJ
Summer Treasury Intern
2018
Made recommendations to improve
Merck Shares Repurchase Program by
modeling various pricing methodologies;
recommendations are adopted by
company’s Treasurer and implemented by
end of internship.
ASUS, Taipei, Taiwan
Controller of Sales and Marketing
2015 – 2017
Doubled APAC regional profit in one year
by providing P&L simulations and analytical
insights for partnering sales and marketing
managers; monitored $1.5B annual revenue
for 14 countries in APAC region.
Controlled $50M annual marketing budget
and allocated to branches strategically;
served as sole APAC representative to
communicate headquarters profit strategy
to overseas sales managers and sales force.
ASUS, Taipei, Taiwan
Finance Analyst
2014 – 2015
Increased $4M profit in 2 years by
optimizing operation process between
sales team and accounting department.
ERNST & YOUNG, Taipei, Taiwan
Auditor
2012 – 2014
Conducted analytical procedures to
detect unusual trends or periodic
variances in financial statements.
RON TAITZ
rtaitz19@gsb.columbia.edu
Strategy and Technology
Yale University
New Haven, CT
BA, Economics, 2015
CONSENSYS INC., Brooklyn, NY
Galileo Strategy Intern
2018
Led the initiative to identify and design
the most viable and lucrative blockchain
solution specifically targeting the
inefficiencies of the pharmaceutical
industry.
Researched and analyzed competitor
strategies and made recommendations to
senior management.
BANK OF NEW YORK MELLON,
New York, NY
Senior Associate
2016 – 2018
Led the BNY Mellon Blockchain Client
Engagement Initiative, which reconciled
client demand for blockchain-based
solutions with the capacity constraints
faced by our blockchain solution
development team.
Directed client engagement strategy to
capitalize on knowledge of the clients and
on insights into industry trends to win
additional mandates, particularly in the
CLO and non-performing loan servicing
space.
SYNPULSE MANAGEMENT CONSULTING,
New York, NY
Associate Consultant
2015 – 2016
Performed market analysis focusing on
demand and competition through market
sizing and revenue estimations,which
identified key market entry points for
Synpulse’s FinTech-centric consulting
services.
ANAND TAMIRISA
atamirisa19@gsb.columbia.edu
Finance and Consulting
University of Texas at Austin
Austin, TX
BBA, 2012
HOUSTON CENTER FOR CLINICAL
RESEARCH, Houston, TX
Director of Operations
2016 - 2017
Created multi-million dollar budgets
for trials with major pharmaceutical
companies, including Bayer, Allergan, and
AbbVie.
Managed staff of seven and recruited
physicians and certified medical assistants
to conduct clinical trials.
Increased projected revenue by $1.5M by
bidding for and winning over 15 clinical
trials for various health conditions.
QUORUM BUSINESS SOLUTONS,
Houston, TX
Senior Consultant
2012 – 2016
Directed a budget for the management
of wind turbines in 10 states that reduced
data retrieval time by 10% and simplified
report generation for daily business
operations among client Land, GIS, and
reporting teams.
Pitched mapping solution to Land
Management team (responsible for North
America assets); awarded $10,000 to
implement.
Developed and customized applications
per user needs by partnering with client
Land/GIS team leads.
NAOMI TUDHOPE
ntudhope19@gsb.columbia.edu
Corporate Development and Strategy
Wesleyan University
Middletown, CT
BA, East Asian Studies, 2011
ADVANCE, New York, NY
MBA Intern, Corporate Development &
Strategy
2018
Conducted due diligence for multi-billion
dollar capital deployment initiative.
Developed go-to-market strategy to
differentiate Advance in competitive
marketplace.
BRUNSWICK GROUP, Shanghai, CN
Account Director
2015 – 2017
Developed and implemented
comprehensive communication and
stakeholder engagement strategies for
clients during business critical moments
affecting reputation and valuation.
EMERGING STRATEGY, Shanghai, CN
Consultant
2014
Oversaw the company’s largest
engagement, global market assessment for
a leading educational testing company.
GBI, Shanghai, CN
Content Marketing & Corporate
Communications Specialist
2013 – 2014
Created GBI’s first marketing strategy
for growing product portfolio of market
intelligence and mobile applications for
China and Brazil’s healthcare industries.
PFIZER, New York, NY
International Public Affairs Consultant
2011 – 2012
Evaluated government regulations and
developed stakeholder engagement
strategies to influence operating
environment.
15
2019 : Wang - Zhou
SHIRLEY WANG
shwang19@gsb.columbia.edu
Business Analytics, Health Tech and Providers
Columbia Mailman School of Public Health
New York, NY
MPH, Health Policy & Management 2019
Princeton University
Princeton, NJ
BA, Economics, 2015
WELLTHIE, INC., New York, NY
Data Intern
2018
Researched the competitive landscape
of health insurtech data capabilities,
evaluated competitive advantage, and
identified third-party data sources to
bolster Wellthie’s data capabilities.
Developed a strategy for future data
projects and created proof of concept
examples related to risk analysis,
predictive analytics, and decision support
for Wellthie’s clients.
COVANCE, INC, Princeton, NJ
Data Analyst II
2015 – 2017
Analyzed clinical trials budgetary data to
improve pricing algorithms and margin
calculation for more accurate multi-million-
dollar budgets.
Partnered with pricing team and other
stakeholders in different departments
to develop tools to programmatically
generate budgetary documents and create
data visualization dashboards.
16 2019-2020 HCIA RÉSUMÉ BOOK
SHERIE ZHOU
szhou19@gsb.columbia.edu
Strategy and Consulting
University of Virginia
Charlottesville, VA
BS, Biology, 2014
STRATEGY&, New York, NY
Senior Associate Intern
2018
Assessed physician and hospital landscape
for a pharmaceutical drug launch, and
developed actionable insights to optimize
salesforce deployment at 150 key hospital
accounts.
Evaluated competitive landscape and
brainstormed the future state for a
company entering the healthcare data
market.
NSF INTERNATIONAL, Washington, DC
Associate Practice Manager
2017
Drove client engagements by developing
proposals, forecasting budgets, negotiating
contracts with VPs and Directors, and
creating supplemental documents to help
clients obtain project approvals from the
C-suite.
Evaluated two acquisition targets,
developed corrective action and
integration plans with client, and
resolved 59 regulatory and manufacturing
deficiencies to improve cardiac device
safety. Managed ten engineers across
three sites.
NSF INTERNATIONAL, Washington, DC
Research Associate
2014 – 2017
Led strategic planning presentation to
firm’s senior management on industry
trends, lead generation, and proposal
success rates. Suggested increased
thought leadership which resulted in
133% more leads for combination product
support (2015 to Q2 2017).
17
2020 : Ascherman - Coman
BEN ASCHERMAN
bascherman20@gsb.columbia.edu
Healthcare Entrepreneurship
and Venture Capital
Columbia University College
of Physicians and Surgeons
New York, NY
MD, 2020
Harvard College
Cambridge, MA
BA, Biology (Economics minor), 2014
NY PRESBYTERIAN HOSPITAL,
New York, NY
Researcher, 2014 – 2015
Developed rodent model to further study
ECMO and analyze its impact on multiple
physiologic parameters.
Consented patients and collected tissue
samples for studies of serum protein levels
in patients with aortic stenosis, and in
patients undergoing treatment for aortic
aneurysms, hypertrophic cardiomyopathy,
and end-stage heart failure.
NATIONAL INSTITUTES OF HEALTH (NIH),
T35 RESEARCH GRANT
New York, NY
Researcher, 2016
Worked in Columbia University Medical
Center’s Department of Orthopedic
Surgery to develop predictive model of
functional outcomes after surgical and
nonsurgical treatments of distal radius and
ankle fractures.
PITANGO VENTURE CAPITAL
Herzilya, Israel
Summer Intern, 2013
Worked with one of Pitango’s biotech
portfolio companies to search for and
establish new areas of market penetration
for novel product.
Researched and analyzed market potential,
growth opportunities, competition,
differentiation, and executive teams of
biotech companies as potential investment
opportunities.
18 2019-2020 HCIA RÉSUMÉ BOOK
LESLYE BARTH
lbarth20@gsb.columbia.edu
Consulting and Private Equity
Vanderbilt University
Nashville, Tennessee
Economics and Corporate Strategy, 2015
BANK OF AMERICA MERRILL LYNCH,
New York, NY
Investment Banking Senior Analyst,
Mergers and Acquisitions
2017 – 2018
Analyzed opportunities for divestitures,
leveraged buyouts, bolt-on acquisitions,
and transaction financings for public and
private companies in industries such as
healthcare, technology and consumer.
Prepared clients for M&A execution
process including the creation of
marketing materials and development of
operating and pro forma financial models
for diligence.
Negotiated concurrent merger agreements
and liaised with clients, outside legal
counsels and public company business
development teams.
BANK OF AMERICA MERRILL LYNCH,
New York, NY
Investment Banking Analyst, Global
Industrials Group
2015 – 2017
Completed 15+ M&A processes and debt/
equity financings for large-cap industrial
companies.
Performed industry benchmarking and
competitive landscape analyses on
business services and chemicals sub-
verticals for weekly client distribution.
ALEXANDRA CAMESAS
acamesas20@gsb.columbia.edu
Management and Marketing
Brown University
Providence, Rhode Island
BA, Business, Entrepreneurship and
Organizations, 2014
CATALYST @ HEALTH 2.0, Brooklyn, NY
Associate Director, 2017 – 2018
Sr. Program Manager, 2017 – 2017
Program Manager, 2015 – 2017
Directed team of five in the management
of commercialization programs that
facilitated partnerships between digital
health startups and enterprise healthcare
firms.
Led market-access program for proven
technology companies looking to grow
their business in the Indian healthcare
market.
Evaluated 330 health tech companies from
29 countries, resulting in the selection of
22 pilots to test solutions in the Indian
market, delivering care to 24,000 patients
across 80 clinical sites.
Analyzed tech pilot outcomes along with
data on company growth, commercial
contracts and funding to generate insights
on program success; Presented findings
and recommendations to client to inform
expansion of the program to a new
emerging market.
DIGITASLBI, New York, NY
Account Executive
2014 – 2015
Defined strategy for personalized
marketing campaign for $5B branded
medication aimed at healthcare
professionals, based on the physician
journey, historical data, customer behavior
and segmentation.
Collaborated with leadership team to
develop tech partnership strategy for a
patient-centered platform that promotes
preventive health measures for better
outcomes.
ZACK CAPLAN
zcaplan20@gsb.columbia.edu
Strategy and Venture Capital
Boston College
Chestnut Hill, MA
BS, Finance and Economics, 2014
INNOVATION & DIGITAL HEALTH
ACCELERATOR – BOSTON CHILDREN’S
HOSPITAL, Boston, MA Pre-MBA Fellow
2018
Performed due diligence on eight
Accelerator applicants, including analyzing
each company’s business model, team
member experience, market opportunity,
competitive landscape, and product
roadmap.
Partnered with three pre-seed digital
health startup founders to develop go-
to-market strategies, including defining
pricing models, establishing key metrics,
identifying resource requirements, and
determining fundraising targets.
DELOITTE CONSULTING, LLP – STRATEGY
& OPERATIONS, Boston, MA
Consultant, 2016 – 2018
Business Analyst, 2014 – 2016
Advised integration of eight newly
acquired hospitals, including working
directly with each acquired hospital’s
CEO and CFO to identify strategic
opportunities and define financial
targets. Project managed five teams for
the system’s subsequent purchase of 18
hospitals.
Established a centralized measurement,
monitoring, and reporting structure for
a non-profit healthcare system with 100+
hospitals operating in 17 states to track
cost saving initiatives against a system-wide
turnaround goal of $800M.
Conducted revenue cycle assessments
for a four-hospital university healthcare
system, a 700+ bed New York hospital,
and a national for-profit oncology hospital
system. Quantified opportunities resulted
in implementation projects.
RENO CHEN LAURENCE COMAN
zchen20@gsb.columbia.edu lcoman20@gsb.columbia.edu
Business Development Technology and Entrepreneurship
and Corporate Strategy
University of Pennsylvania
Case Western Reserve University Philadelphia, PA
New York City, NY BS, Economics with Finance Concentration
MS, Operations Research, 2014 at The Wharton School, 2013
BA, International Studies and Hispanic
Guangzhou University Studies (double major) at the College of
Guangzhou, China Arts and Sciences, 2013
BS, Industrial Engineering Research, 2014
VECTOR CAPITAL, San Francisco, CA
SANDOZ, A NOVARTIS DIVISION, Private Equity Investment Associate
Princeton, NJ 2016 – 2018
Senior Manager, Strategic Insight
Evaluated investment opportunities in
and Analytics
enterprise software companies through
2018 - Present
financial modeling and extensive due
Supported traditional pharmaceutical diligence.
and digital asset commercial launch
Executed over $300M of add-on
(commercial due diligence, payor
acquisitions for two portfolio companies,
research, HCP/patient research and
working closely with executive teams on
segmentation, and FF sizing & targeting).
financial modeling and due diligence.
Drove operational excellence projects to
Led customer retention and acquisition
align with strategic imperatives (e.g. IDN
analyses to optimize portfolio companies’
contracting process & market intelligence
go-to-market strategies.
reporting platform).
Led external consultants/cross-divisional GREENHILL & CO., LLC, New York, NY
team on analytics and brand insights Senior Analyst
projects. 2013 – 2016
First analyst in firm history promoted to
Analyst - Manager, Pricing Analytics
third-year role.
2014 - 2018
Led two-month global analyst and
Led cross-functional team and external
associate training program.
consultants to build decision support
platform. Executed M&A, buyout and strategic
advisory transactions across a variety of
Managed pricing for over $1B customer
sectors.
portfolio with hands-on experience
running analytics for deal designing and
customer negotiation.
Managed launch projects (evaluate
pipeline asset and design launch/pricing
strategy) as pricing liaison.
Established price increase algorithm and
processes for the US generic market.
19
2020 : Efron - Guzik
ALEX EFRON
aefron20@gsb.columbia.edu
Finance and Corporate Development
Pomona College
Claremont, CA
BA, Neuroscience, 2011
ARBITER PARTNERS, New York, NY
Summer Research Analyst
2018
Performed business valuations, merger
analyses, competitive and industry
research for various life science,
technology, and healthcare services
companies.
AARETE, New York, NY
Manager
2015 – 2018
Directed consulting engagements in
strategy, data analytics, and profit &
operations improvement for leading
managed care organizations and
healthcare systems.
Led initiative to improve clinical outcomes
and achieve $3M in annual savings for a
Fortune 100 Medicaid MCO’s national
organ transplant program.
Reengineered the systems and processes
underlying revenue, claims, and reporting
for a regional health plan, rectifying
financial and regulatory deficiencies.
HURON CONSULTING GROUP,
New York, NY
Associate
2011 – 2015
Delivered consulting solutions in
operations, strategy, and regulatory
compliance for pharmaceutical and
medical device companies.
Designed and implemented process
improvements and fair market valuation
(FMV) models to develop global payment
structures for healthcare professionals,
wholesale distributors, specialty
pharmacies, and GPOs.
20 2019-2020 HCIA RÉSUMÉ BOOK
ISAIAH EINZIG
ieinzig20@gsb.columbia.edu
Finance
Cornell University
Ithaca, NY
BS, Biology & Society, 2012
BS, Applied Economics, 2012
MADRYN ASSET MANAGEMENT,
New York, NY
Associate
2015 – Present
Acted as part of founding team as entity
spun out of Visium Asset Management and
sole associate on >$170M of investments
across customized debt and equity
structures within specialty pharma,
diagnostics, and device investments.
Attend conferences and interact with
CEO/CFO teams to source and evaluate
investment opportunities.
Onboarded, trained, and managed two
junior associates.
Consult 10 hours a week while in school.
MTS HEALTH PARTNERS, New York, NY
Analyst
2014 – 2015
Sole analyst on $275M of private financings
and $200M royalty monetization.
Constructed financial valuation models
including discounted cash flow, private
placement capitalization, royalty
monetization, accretion/dilution, and
mergers and acquisitions analyses.
IMS CONSULTING GROUP,
New York, NY
Consulting Analyst
2012 – 2014
Created and implemented global pricing
and market access strategies.
Advised on clinical trial design, value
messaging, health economic studies, and
pipeline prioritization.
MICHELLE FERBER
mferber20@gsb.columbia.edu
Technology and Management
Northwestern University
Evanston, IL
BS, Material Science and Biomedical
Engineering, 2015
EPIC SYSTEMS CORPORATION,
Verona, WI
Technical Coordinator
2016 – 2018
Managed client relationship with Hospital
for Special Surgery IT team, supporting
customer teams across clinical, revenue
and scheduling applications.
Led strategic planning initiative to improve
patient engagement through enhancing
patient portal functionality.
Technical Services
2015 - 2018
Provided clinical application support
to hospital clients by conducting
weekly meetings with client analysts
covering training, troubleshooting, and
enhancement requests resulting in
increased provider satisfaction.
Coordinated health information exchange
performance across Epic customers to
meet regulatory programs requirements.
Streamlined process to review physician
and nurse efficiency data for hospitals and
provide recommendations.
CENTER FOR INNOVATION AND
GLOBAL HEALTH TECHNOLOGIES
Evanston, IL
Research Assistant
2012 – 2015
Optimized precision and performance of
an extraction process and assay as a low
cost, point-of-care nucleic acid test for
Multi-Drug Resistant Tuberculosis.
TESS FINKEL
tfinkel20@gsb.columbia.edu
Management
Columbia University
New York, New York
BA, 2010
THE KINETIX GROUP, New York, NY
Senior Director
2017 – 2018
Managed European headquarters in
Dublin, Ireland ensuring full compliance
with Irish revenue and business authorities,
establishing transfer pricing protocols, and
implementing cross-office workflows.
Conducted competitive landscape
analysis, market shaping, and value
proposition development in the insurer
and health system channel for first FDA-
approved Biosimilar.
Drove practice transformation and data
initiatives in the largest urology group in
America for innovative payment reform
program aimed at improving oncology care.
THE KINETIX GROUP, New York, NY
Director
2013 – 2018
Led multiple market access and payor
marketing projects for pharmaceutical
clients.
Preformed internal change management,
market positioning, research, branding,
and annual planning activities for a $7B eye
care company to establish a new strategic
account management organization.
Researched, authored, and pitched new
business presentations to pharmaceutical
companies and national health systems,
presenting a patient-centric approach to
market access.
LISEBETH FORBES
lforbes20@gsb.columbia.edu
Consulting and Strategy
Cornell University
Ithaca, NY
BA, Genetics and Classics, 2013
PwC, New York, NY
Manager
2018
Managed operational transformation
at US Department of Veterans Affairs -
Office of Community Care, including a
full process redesign of core business
functions (eligibility, authorization, care
management, provider payment, member
service and network management),
business process implementation, change
management, communications and
training.
Senior Associate
2015 – 2018
Redesigned a health system’s care
management model across their 10
hospitals through orchestrating three
100+ person interactive design sessions
with frontline staff, doctors and leaders
with the goal of providing the right level
of patient care based on disease acuity
in the right care setting to reduce acute
care length of stay, cost of care, and
increase patient experience.
Identified over $120M in margin
enhancement opportunities across an
11 hospital health system in their 15+
non-clinical shared services departments
and worked directly with leaders to
further analyze cost drivers and prioritize
initiatives to align costs with the system’s
strategic priorities.
Associate
2013 – 2015
Analyzed healthcare provider deals
(operational due diligence, clinical
synergies, volume trending), revenue
cycle (cash collections trending over
baseline), and academic medical centers
(funds flow).
BEN GUZIK
bguzik20@gsb.columbia.edu
Entrepreneurship, Technology and Finance
University of Pennsylvania
Philadelphia, PA
BA, Health and Societies, 2014
MERCER, New York, NY
Associate
2014 – 2018
Consulted large clients on healthcare
strategy including medical, prescription
drugs, vision and wellness benefits.
Forecasted healthcare costs analyzed key
areas of healthcare spend and proposed
solutions to mitigate costs.
Acted as key contact for office on
healthcare startups and organized
informational presentations for consultants
by healthcare startups including behavioral
health and diabetic management
companies.
Coordinated medical insurance RFPs and
summarized and illustrated results for
executive management.
NORTH SHORE LIJ TRANSPLANT
CENTER, Manhasset NY
Administrative Intern
Summer 2013
Collaborated on a three-person consulting
team focused on strategic outreach
projects aimed at increasing patient
volume.
Wrote business plan and presentation for
establishment of an outpatient.
21
2020 : Hamlin - Landsman
BRITTANY HAMLIN
bhamlin20@gsb.columbia.edu
Finance and Technology
Mailman School of Public Health
New York, NY
MPH, 2021
Cornell University
Ithaca, NY
BA, Biology and Society, 2015
PUTNAM ASSOCIATES, Boston, MA
Senior Associate Consultant
2017 – 2018
Executed valuation for successful
partnership between pre-IPO
biotech company and $3B Japanese
pharmaceutical manufacturer in the
Japanese depression market.
Led team of 5 to develop financial
forecast for $1B+ anti-depressant across
7 developed markets (US, EU5, Japan)
by integrating provider and payer key
opinion leader (KOL) feedback, company
financials, and secondary market research.
Associate Consultant
2016 – 2017
Built dynamic financial model for leading
pharma company in immuno-oncology
space evaluating strategic pricing and
contracting structures to hedge against
competitive entrants.
BRIGHAM AND WOMEN’S HOSPITAL,
Boston, MA
Research Coordinator
2015
Managed engagement with 400 national
sites and 7,000 patients on an NIH-
funded clinical trial, while coordinating
diverse teams in the successful delivery of
cardiovascular trial products.
Initiated audits and resolved $10,000 in
payment discrepancies across 400 sites;
Developed payment checklist to ensure
quality control which resulted in 100% on-
time delivery.
22 2019-2020 HCIA RÉSUMÉ BOOK
PRATEEK HANDA
phanda20@gsb.columbia.edu
Management and Consulting
Shri Ram College of Commerce
New Delhi, India
BA, Economics, 2013
FIDELITY GROWTH PARTNERS,
Mumbai, India
Investment Professional
2015 - 2018
Led product and market diligence for key
plasma products, and created investment
thesis to conclude India’s first PE
transaction in the space.
Tested efficacy of marketing plan of optical
retail chain by leading a consumer survey;
used findings to simplify and redesign
pricing structure.
Examined commercial viability of a
portfolio of twenty generic molecules
across several parameters to gain approval
for investment.
AVENDUS CAPITAL, Mumbai, India
Investment Banking Analyst
2014 - 2015
Identified potential cross-border and
domestic M&A targets for healthcare and
IT clients.
Selected, as part of a 3-member team, to
set up healthcare practice; generated a
20+ lead pipeline.
ALEXANDER HRYHOROWYCH
ahryhorowych20@gsb.columbia.edu
Consulting and Management
Columbia Business School
New York, NY
MBA, 2020
ZS ASSOCIATES, New York, NY
Associate Consultant
2017 – 2018
Executed due diligence on business
development opportunities for Fortune
100 biopharma client.
Served in contract position as Global
Commercial Portfolio Director at a Fortune
100 pharmaceutical firm.
Revamped commercial strategy for a $1B
vaccine brand, resulting in 4% increase in
one-year sales.
Served as assistant launch manager for an
oncology drug gaining a new indication.
Business Analyst
2015 – 2017
Drove turnaround of an underperforming
hemophilia brand by diagnosing cause of
patient loss and recommending remedy
strategies.
Designed patient-flow forecast model
distributed to 45 country brand leads.
ALPHASIGHTS, New York, NY
Lead Analyst, Analyst
2013 – 2015
Managed relationships with ~50 clients
from a management consulting firm, driving
over $400K in annual revenue.
Performed opportunity assessment to
prioritize growth practice areas in largest
client account.
DANIELLE LABARBIERA JENKS
djenks20@gsb.columbia.edu
Technology and Strategy
Cornell University
Ithaca, NY
BS, Chemical and Biomolecular
Engineering, 2015
DELOITTE CONSULTING, New York, NY
Strategy and Analytics Consultant
2017 – 2018
Developed optimized provider data
processes for $35B+ health plan,
achieving annual savings of $15M+ by
reducing redundant technology and
increasing employee efficiency.
Pioneered value-based care payment
strategy that enabled health plan to align
technology and operations across five
states.
DELOITTE CONSULTING, New York, NY
Business Technology Analyst
2015 – 2017
Developed 250+ business requirements
by prioritizing and redesigning digital
user experience for boutique retailer.
Analyzed F500 provider’s data usage
and designed streamlined data storage
procedure, reducing storage costs by
98%+ and cutting response time by 50%+.
LIZA KIND
lkind20@gsb.columbia.edu
Consulting and Strategy
University of Michigan
Ann Arbor, Michigan
BA, Political Science, Complex Systems, 2014
ENGLEWOOD HEALTH, Englewood, NJ
Chief of Staff
2015 – 2018
Served as extension of CEO leading
strategic initiatives, spearheading
organizational improvements, and
increasing financial performance.
Collaborated with senior leadership
to create ten year strategic plan; led
behavioral health pillar of plan with focus
on outpatient expansion.
Oversaw $6.5 million budget and over 100
employees of Food & Nutrition Services
Department.
FTI CONSULTING, New York, NY
Health Solutions Consultant
2014 – 2015
Developed litigation support for large
national retail pharmacy, including forensic
analysis of large transaction data sets.
Identified opportunities for revenue
optimization for ten national health
systems.
JAMIE LANDSMAN
jlandsman20@gsb.columbia.edu
Consulting and Strategy
Cornell University
Ithaca, NY
BA, Policy Analysis and Management, 2014
THE ADVISORY BOARD COMPANY,
Washington, DC
Senior Analyst
2018
Advised hospital c-suite and finance
executives on topics including cost-control
strategies, federal payment policies,
revenue cycle optimization.
Led workstream on optimizing revenue
capture best-practices; Designed revenue
cycle maturity model to assess client
capabilities.
Analyst
2016
Authored five white papers and
contributed to four 90-minute
presentations on physician alignment,
consumer-focused healthcare, and
organizational transformation of operations
for 3,000+ hospital leaders.
23
2020 : Li - Mustafa
CHLOE LI, CPA
zhli20@gsb.columbia.edu
Finance and General Management
Columbia Business School
New York, NY
MBA, Healthcare and General Management
2020
Emory University
Atlanta, GA
BBA, Finance and Accounting
2012
CASTLETON COMMODITIES INT’L,
Stamford, CT
Associate Director, Tax Manager
2015 – 2018
Managed team of four professionals to
ensure accurate income tax filings and
restructuring of 50+ legal entities with
complex legal structures across multiple
jurisdictions including U.S., Canada,
Singapore, China and Europe.
Built robust analyses of $17BN annual sales
data from SAP to establish company’s
first-ever state apportionment allocation
method, saving on tax assessments in 13
states.
Implemented tracker process within Tax,
Treasury, Credit, Risk and Legal teams
to document company re-domiciliation
and daily operations under FATCA and
common reporting standard regimes;
reduced turnaround time by 10-14 days per
request
KPMG LLP, Stamford, CT
Senior Associate, Tax
2014 – 2015
Led teams of 10+ tax professionals in tax
compliance and planning engagements
with annual budget totaling $10MM for
clients across banking, mutual funds, real
estate, energy, retail and Technology,
Media & Telecommunications sectors
DELOITTE TAX LLP, Atlanta, GA
Tax Consultant
2012 – 2014
24 2019-2020 HCIA RÉSUMÉ BOOK
ERIK MAI
emai20@gsb.columbia.edu
Finance and Entrepreneurship
Columbia College
New York City, NY
BS, Biochemistry and Business Management,
2013
MODERNA THERAPEUTICS,
Cambridge, MA
Senior Manager, Corporate Strategy
2017 – 2018
Created valuation materials for $500M
Series-G private placement.
Collaborated with GMP manufacturing
team to create roadmap to lower COGS.
Implemented new process to assess
risk across the portfolio to influence
development candidate nomination.
Devised business plans for clinical
programs considering commercial
opportunity, unmet need, risk,
development speed/cost, and synergies
across the portfolio.
HEALTH ADVANCES, Boston, MA
Consultant, Case Team Leader
2013 – 2016
Strategy consultant advising clients across
the healthcare spectrum: biopharma,
medical devices, diagnostics, HIT, and
healthcare services.
Led diligence efforts to evaluate
competitive landscapes and forecast peak
sales across different scenarios.
Constructed a ‘go-to-market’ blueprint
for a novel therapeutic capturing sales
and marketing requirements and HEOR
materials.
Evaluated life-cycle management strategies
for blockbuster brand.
Chair of the Business Analytics and
Forecasting Committee.
KUNAL MALHOTRA
kmalhotra20@gsb.columbia.edu
Consulting
Motilal Nehru National
Institute of Technology,
Allahabad, India
B.Tech, Electronics and Communication
2012
ZS ASSOCIATES,
New York, NY
Project Lead, 2017 - 2018
Senior Analyst, 2016 - 2017
Led team of cross-functional experts to
examine market scenarios and business
assumptions to enable decision around
$4B acquisition.
Conducted commercial due diligence to
guide strategic investment decisions.
Optimized size and design of sales force
teams to accommodate new product
launch.
Managed relationships with multiple clients
and coordinated with offshore technical
staff to deliver predictive analytic projects.
New Delhi, India
Associate Consultant, 2014 – 2016
Associate, 2012 – 2014
Developed patient journey insights and
measured performance of sales channels
by analyzing patient level data.
Assessed multi-channel promotional
strategy by identifying and targeting
physician segments based on promotion
receptivity.
Created statistical tool to predict post LoE
market share erosion.
Analyzed speciality pharmacy sales
and interactions data to measure store
performance.
EMMA McGREGOR
emcgregor20@gsb.columbia.edu
Consulting, Strategy and Technology
University of Michigan
Ann Arbor, Michigan
BSE, Industrial and Operations Engineering,
2015
EMTEC, INC., Chicago, IL
Senior Consultant
2018
Designed and built an integrated platform
to consolidate a financial services
client’s nine disconnected systems used
for housing financial information and
performing daily activities.
Conducted client team interviews
to gather and document over 200
requirements across three business areas
and identified specific operational and
workflow solutions.
Presented project plans, process
improvements, and industry best practices
to C-level client stakeholders.
Owned the training and knowledge
transfer of a client’s financial processing
and data maintenance to a new hire.
NATIONWIDE CHILDRENS HOSPITAL
Columbus, OH
Business Process Improvement Intern
2013 – 2014
Mentored hospital managers through
internal operational excellence training
focused on teaching Lean and Six Sigma
principles through department-specific
projects.
Led a project to predict Admissions
volume and presented hourly staffing
recommendations to accommodate the
expected number of patients over the
16-hour day.
Conducted time studies and analyzed
results to recommend the number of time
clocks needed to meet demand.
ANISHA MUKHERJEE ZAID MUSTAFA
amukherjee20@gsb.columbia.edu zmustafa20@gsb.columbia.edu
Strategy and Corporate Development Consulting
Duke University McGill University
Durham, North Carolina Montreal, Canada
BSE, Biomedical Engineering, 2014 BA & BSc., Molecular Biology and
Economics, 2015
WG GROUP, New York, NY
Senior Analyst DHL CONSULTING, Miami, FL
2018 Senior Management Consultant
2018
Organized and conducted advisory
boards to solicit feedback from key Led various international engagements
stakeholders on delivery model of to advise Life Sciences and Healthcare,
Schedule III drug and developed key Technology and Logistics clients.
recommendations for implementation.
Headed business development for Life
Leveraged findings from systematic Sciences sector as youngest-ever board
literature review to determine clinical member, directly acquiring 10 new
endpoints to guide clinical trials for projects (>50% success rate).
regenerative medicine asset.
MEAKINS CHRISTIE LABORATORIES,
OUTCOME HEALTH, New York, NY Montreal, Canada
Associate, Sales Strategy and Operations Research Intern
2017 2014
Collaborated with COO to develop new Designed and carried out
organizational structure that leveraged experimentation on the effects of IL-
pharma industry insights. 17a on cytokine production in severe
persistent asthma, resulting in paper
Partnered with SVPs to track pipeline publication.
of ~$25M, pacing to quota and provide
strategies to maximize size of deals
ranging from $100K - $1M.
CBPARTNERS, New York, NY
Senior Analyst
2015 – 2017
Conceived, architected, and piloted
global rotation program for employees
to gain international exposure and build
more cohesive culture across offices;
resulted in 3 applicants in first year;
completed 7-month rotation in London,
UK.
Built dynamic pricing tool to predict
prices of future drugs agnostic of clinical
data in EU5 used by client for forecasting.
25
2020 : Nimmo - Reis
JOHN NIMMO
jnimmo20@gsb.columbia.edu
Private Equity and Management
Dartmouth College
Hanover, NH
BA, History, 2013
GEMINI INVESTORS, Wellesley, MA
Private Equity Associate
2015 – 2018
Executed six new platform investments
across a range of industries including home
health and dermatology.
Built financial models, conducted business
due diligence, authored and presented
investment committee memorandums and
managed third party transaction advisors.
Monitored ten portfolio companies,
supporting management teams’ strategic
planning efforts, additional financing
needs, and acquisition screening and
execution.
Evaluated over 300 investment
opportunities annually.
PARTHENON-EY, Boston, MA
Senior Associate, 2015
Associate, 2013 – 2015
Provided M&A advisory, market due
diligence and growth strategy services to
private equity and corporate clients within
the healthcare practice.
Conducted primary and secondary
research, executed customer segmentation
analysis, and prepared presentations to
advise clients on key strategic questions.
Co-Chair of Summer Associate Program
and Dartmouth Undergraduate Recruiting
Captain.
26 2019-2020 HCIA RÉSUMÉ BOOK
MARGARET O’BRIEN
mobrien20@gsb.columbia.edu
Social Enterprise and Finance
Bucknell University
Lewisburg, PA
BA, Economics and Spanish, 2014
HEALTH ADVANCES, Weston MA
Engagement Manager, Consultant
2017 – 2018
Developed growth-focused strategic
recommendations for 50+ clients
across healthcare industry, including
biotech, pharmaceutical, medical device,
diagnostics, and Health IT companies,
PE/VC funds, and healthcare trusts/
foundations.
Managed case teams of 3-8 consultants,
overseeing work-streams, synthesizing
findings, and presenting to clients.
Devised US and EU market access
and pricing strategies for a platform
biotechnology company with several Phase
II and III assets.
Senior Analyst, Analyst
2014 – 2017
Prioritized >100 grantees for a large
healthcare trust to partner with to
advance the trust’s core mission of curing
Type 1 diabetes.
Assessed the revenue trajectory of
several antibiotic classes as part of a due
diligence.
Prioritized organic and inorganic growth
opportunities for capital deployment on
behalf of an aspiring CNS biotech.
Built revenue forecasts, capturing
competitors, reimbursement, physician
reception, and payer feedback to feed into
NPV models.
UNITED STATES SENATE, Washington D.C.
Legislative Intern, 2012
Assisted healthcare legislative
correspondent by attending congressional
meetings, researching policy areas, and
crafting briefings/legislation.
MATTHEW PESESKY
mpesesky20@gsb.columbia.edu
Investment, Management and Technology
University of Virginia
Charlottesville, VA
BA, Distinguished Majors
Program in History, 2012
ONECITY Health
Data Science Intern
October 2018 – present
Structuring and analyzing referral and
service data through the NowPow program
to empirically maximize care effectiveness.
Reporting to the Chief Analytics Officer.
OPTUM, Washington, DC
Senior Research Consultant
2017 – 2018
Directed product creation for the firm’s
medical technology unit (150 clients) to
provide increased data transparency and
identify opportunities for strategic growth.
Spearheaded development and release
of data-focused product enhancements,
leading to 99% medical device client
retention.
THE ADVISORY BOARD COMPANY,
Washington, DC
Consultant
2012 – 2017
Served as acting practice manager for
$16M Health Care Industry unit from
February-July 2017. Led five-member
research staff and partnered intensively
with 18-member commercial team.
Completed custom projects for 23 of the
25 largest global medical device firms.
ANDREA RADKE
aradke20@gsb.columbia.edu
Consulting and Marketing
Brown University
Providence, Rhode Island
AB, Biology & Pre-Medicine, 2013
UNITEDHEALTHCARE, Minnetonka, MN
Program Manager of Advanced Reporting &
Analytics for Provider Services
2017 – 2018
Spearheaded executive reporting and data
readiness for health plan expansion adding
45,000 providers to UHC’s central region.
Facilitated application upgrade by
ensuring cross-functional collaboration and
implementation between business and IT
to maintain data security and reporting
reliability for 650,000 providers.
UNITEDHEALTHCARE, Minnetonka, MN
Manager of Customer Care Reporting
2016 – 2017
Managed 12-person global reporting team
constructing visual reports from UHC
national call center data.
Hired top-talent to bolster operational
performance. Tripled productivity
in database optimization project.
Transformed data run time to expedite
data delivery to customers.
Led first UHC provider experience
reporting initiative on quality metrics such
as issue turnaround time and inventory
control.
OPTUM, Eden Prairie, MN
Healthcare Payer Consultant
2013 – 2016
Leadership Acceleration Program
Graduate: Achieved high customer
satisfaction on a variety of healthcare
consulting engagements while completing
over 60 trainings in under three years.
MODAK RAJ
mraj20@gsb.columbia.edu
Management and Consulting
St. John’s University, College of Pharmacy
and Health Sciences School
New York, NY
MS, Industrial Pharmacy, 2012
Manipal University, College of
Pharmaceutical Sciences,
Manipal, India
BS, Pharmaceutical Sciences, 2009
CONTINEO HEALTH, New York, NY
Practice Lead, Population Health
2012 – present
Led and advised institutional healthcare
client on implementing electronic health
record systems.
Led and advised healthcare organization
and accountable care organizations to
meet the healthcare regulatory reporting
tied to payor based financial incentives.
Evaluated investment opportunities
for seed stage funding in high impact
healthcare segment.
STEPHEN REIS, MD
sreis20@gsb.columbia.edu
Consulting and Private Equity
New York Medical College, Valhalla, NY
MD, 2007
University of California, San Diego
San Diego, CA
BS, Biochemistry and Cellular Biology, 2003
COLUMBIA UNIVERSITY IRVING MEDICAL
CENTER, New York, NY
Assistant Professor of Radiology, Director of
Interventional Radiology Research
2016 – Present
Advised and Implemented switchover to
Epic Electronic Medical Records as part of
the Clinical Leadership Group.
Directed Interventional Radiology Services
at NYP Lawrence hospital and oversaw
20% year over year growth.
UT SOUTHWESTERN MEDICAL CENTER,
Dallas, TX
Assistant Professor of Radiology,
Interventional Radiology Quality
Improvement Liaison
2013 – 2016
Designed and managed the interventional
radiology quality improvement program.
Lead the interventional radiology division
in research production during 3-year
tenure.
27
2020 : Rivera - Rusinkiewicz
ARMANDO RIVERA
arivera20@gsb.columbia.edu
Strategy and Finance
University of Rochester
Rochester, NY
BA, Financial Economics, 2012
SURESCRIPTS LLC, Arlington, VA
Senior Corporate Strategy Analyst,
2017 – 2018
Corporate Strategy Analyst,
2015 – 2017
Collaborated on all corporate strategy
activities reporting into the office of the
CEO.
Tracked companies and monitored trends
in the pharmacy, PBM and health IT
subsectors; crafted market briefings and
reports to update the organization and
provide context around material events.
Validated and secured approval for new
transaction pricing strategy through
scenario modeling of adoption, utilization
and revenue generation for multi-sided
network product; resulted in >40% monthly
transaction volume increase in 9 months.
Acted as an internal consultant and
analytical lead on diverse set of projects,
including: channel partner strategy,
customer incentive analysis, product
strategy, business model transformation
and white paper authoring.
IMS HEALTH, New York, NY
2013 – 2015
Created client dashboards for analysis of
pharmaceutical sales and associated price
concessions across distribution channels
using Tableau data visualization software.
Linked and standardized customer data
sets from current and legacy revenue
management systems using Microsoft SQL
Server.
28 2019-2020 HCIA RÉSUMÉ BOOK
JOANNA ROBERTS
jroberts20@gsb.columbia.edu
Pharmaceutical and Biotechnology
University of Pennsylvania
Philadelphia, PA
BA, Philosophy, Politics, and Economics, 2015
DELOITTE & TOUCHE, New York, NY
Consultant
2017 – 2018
Provided regulatory and compliance
services to pharmaceutical, biotechnology,
laboratory, and medical device clients.
Implemented a risk assessment and
mitigation planning process for an opioid
addiction manufacturer, including systems
and transactions reviews and field force
monitoring.
HURON CONSULTING GROUP
New York, NY
Analyst
2015 – 2017
Improved and maintained compliance with
industry guidelines and federal regulations
for pharmaceutical, biotechnology,
laboratory, and medical device clients.
Developed policies, procedures, and
frameworks to support healthcare
professional management including
contracting, fair market value
determination, and auditing and monitoring
in domestic and EMEA markets.
ERNIE RODRIGUEZ-DUMONT
erodriguezdumont20@gsb.columbia.edu
Finance
Columbia University College
of Physicians and Surgeons
New York, NY
MD, 2008
University of Puerto Rico, Rio Piedras
San Juan, PR
BS, Chemistry, 2004
NYU LANGONE HOSPITAL, Brooklyn, NY
Attending Physician
2013 - 2018
Supervised and managed operation
of nurses and residents teams in the
diagnosis, triage, treatment, and delivery of
obstetrical patients in a Labor and Delivery
Unit.
Performed minimally-invasive gynecologic
surgeries, including life-saving and
emergent procedures.
Awarded with The American College of
Obstetricians and Gynecologists CREOG
National Faculty Award and twice with the
Association of Professors of Gynecology
and Obstetrics Excellence in Teaching
Award.
MEMORIAL SLOAN KETTERING
CANCER CENTER, New York, NY
Research Fellow
Analyzed medical records and identified
relevant information to feed into a
department-wide database used for
research in innovative surgical techniques
for advanced gynecological cancers.
ICAHN SCHOOL OF MEDICINE AT
MOUNT SINAI HOSPITAL, New York, NY
Ob/Gyn Resident Physician
2008 - 2012
Synthesized current labor management
research and presented findings in
departmental Grand Rounds.
ARIEL ROKITO
arokito20@gsb.columbia.edu
Entrepreneurship and Private Equity
Cornell University
Ithaca, NY
BS, Policy, Analysis & Management, 2015
ANALYSIS GROUP, New York, NY
Senior Analyst
2016 – 2018
Defined market size for various disease
areas to estimate the financial impact
to insurance payers of the launch of
new medical interventions; constructed
models that predicted annual cost
savings ranging between ~$2M and $5M.
Developed econometric model to
quantify costs and benefits of a novel
gene therapy in pediatric oncology;
model was submitted to 8 government
drug approval agencies across Europe
and Asia and drug received EU approval
in August 2018.
Managed team of three analysts and led
meetings with pharmaceutical client to
present economic model for pipeline
hemophilia treatment; built model which
created transparency of competitive
treatment landscape and was used by
clients in pricing decisions.
Analyst
2015 – 2016
Quantified damages from off-label
promotion of pharmaceutical drugs
in $280M commercial disputes case;
created exhibits from medical claims
data used in the expert testimony of
a research associate at the National
Bureau of Economic Research.
Conducted statistical analysis of survey
data for 960 patients with diabetes
(across 7 countries) to quantify factors
that drive insulin adherence; results were
presented at the 77th Scientific Sessions
of American Diabetes Association.
TANYA ROSENBLUT
trosenblut20@gsb.columbia.edu
Management and Social Enterprise
Columbia Business School
Columbia University Mailman
School of Public Health
New York, NY
MBA/MPH, 2020
BRUNSWICK GROUP, New York, NY
Account Director
2015 – 2018
Led market research and data analytics
projects on corporate reputation, multi-
stakeholder messaging, and corporate
crisis management for Fortune 500
companies.
Developed a multi-stakeholder reputation
tracker for a large US insurance provider,
the results of which were delivered to the
CEO’s team to inform strategic decisions
for the company.
Conducted an in-depth provider
communications audit for a Fortune 500
healthcare company and developed an
optimized document approval process that
prevents employee burnout and reduces
expenses.
THE DATING RING, New York, NY
Matchmaker
2015 – 2016
Leveraged proprietary software and
interpersonal relationships expertise to
identify optimal matches for members.
ECONOMISTS INCORPORATED,
Washington, DC
Research Associate
2012 – 2014
Performed statistical and economic
analysis using Stata and SPSS for economic
litigation casework, primarily in the
provider space.
Evaluated complex datasets to create
tangible deliverables presented as expert
testimony to the DOJ and FTC.
STEPHANIE RUSINKIEWICZ
srusinkiewicz20@gsb.columbia.edu
Management and Marketing
Stevens Institute of Technology
Hoboken, NJ
ME, System Engineering, 2011
BE, Biomedical Engineering, 2011
INTEGRA LIFESCIENCES, Tullamore, Ireland
Quality Manager
2017 – 2018
Department head overseeing 17.
Instituted personal accountability culture
that increased production plan attainment
by 25% and 50% improvement in Quality
scorecard.
INTEGRA LIFESCIENCES, San Diego, CA
Site Quality Lead
2016 – 2017
Transformed manufacturing site from low
performer to a division leader which lead
to a premium sale price in force divesture.
Restructured & drove site goals to achieve
a 30% increase is capacity.
INTEGRA LIFESCIENCES, Plainsboro, NJ
Senior Quality Engineer & Quality
Compliance Specialist
2013 – 2016
Trained 12 sites globally on inspections
management and managed 8 successful
FDA inspections.
INTEGRA LIFESCIENCES, Andover, UK &
Plainsboro, NJ
Rotational Leadership Development Program
2011 – 2013
Received 510k regulatory approval.
Facilitated International Clinical Trial.
Implemented new customer complaint
process, resulting in 70% decrease in cycle
time.
29
2020 : Satish - Thomson
SHRUTI SATISH
ssatish20@gsb.columbia.edu
Marketing and Technology
Yale University
New Haven, Connecticut
BA, Economics, 2014
DELOITTE CONSULTING, Washington, DC
Senior Consultant
2018
Advised strategy and implementation of
Navy program initiatives improving access
and care coordination for 83,000+ chronic
pain patients across 7 military hospitals.
Designed, piloted, and led three-fold
expansion of opioid safety initiative;
developed messaging, recruited clinician
liaisons and coordinated analytics-driven
patient monitoring efforts, reducing
number of patients on long-term opioid
therapy by 15%.
Consultant
2016 – 2018
Built consensus across multidisciplinary
clinician team to develop first military
policy documenting physician protocols for
managing long-term opioid patients.
Identified Military Health System use case
for patient-reported outcomes collection
technology; placed 3rd in account-wide BD
contest after pitching solution offering to
firm leadership.
Analyst
2014 – 2016
Engaged end users to understand and
communicate requirements to design
team, increasing functionality and user
adoption during FDA implementation
of workflow management platform to
expedite review of generic drugs.
Synthesized leading practices from market
research to advise Navy Chief Medical
Officer on creation, socialization and
implementation of new organizational
operating model to better enable provider-
led care delivery innovation, earning top
leadership approval.
30 2019-2020 HCIA RÉSUMÉ BOOK
DANIEL SCHWEBER
dschweber20@gsb.columbia.edu
Entrepreneurship and Strategy
University of Michigan
Ann Arbor, Michigan
BA, 2010
ZOCDOC, New York, NY
Dedicated Advisor
2017 – 2018
Enterprise sales & account management
professional focused on hospital client
accounts.
Directly oversee multiple metro markets
representing $3.5M in annual contracts,
growing current and new accounts within
territory.
Manage a team of 3 focused technical
implementations, account service, and
sales.
EVERDAY HEALTH, New York, NY
Director, Community Development
2016 – 2017
Led business development, account
management, operations, and customer
support for software business focused on
hospitals and medical schools (acquired
for MD).
Keynote speaker at medical education
industry events.
FORMD, New York, NY
Director, Community Development
2013 – 2015
Grew business from 0 to 100 hospital
accounts.
HURON CONSULTING GROUP, Chicago, IL
Healthcare Consultant
2011 – 2013
Directed enterprise software
implementations for 100s of users at
various health systems.
Integrated billing and collections function
for 153 hospital system into consolidated
center.
VICTORIA SERRANO
vserrano20@gsb.columbia.edu
Management, Operations
and Clinical Research
CUNY School of Public Health
at Hunter College,
New York, NY
MPH, 2005
COLUMBIA UNIVERSITY MEDICAL
CENTER, New York, NY
Administrative Director &
Director of Clinical Research
2002 – Present
Handle all aspects of operations for the
Center’s outpatient clinic, clinical research
and basic science laboratory sectors.
Oversee all HR, administrative and
financial matters for the 26 staff & faculty
that comprise the Center.
NEW YORK UNIVERSITY LANGONE
MEDICAL CENTER, New York, NY
Program Coordinator
2009 – 2011
Focused on all protocol development,
regulatory and financial aspects for 20+
clinical trials, while supervising 4 clinical
research coordinators.
Created and negotiated budgets for
all hematology oncology clinical trials
increasing the per-patient costs by
approximately 25% in most budgets.
COLUMBIA UNIVERSITY MEDICAL
CENTER, New York, NY
Senior Research Manager
2008 – 2009
Supervised the conduct of 7 clinical trials
and database projects and 3 research staff
within the Pancreas Center.
Supervised and assisted with the forensic
work and implemented extensive
corrective action plans, SOPs and SPIs to
obtain approval from the IRB and OHRP
for a clinician to re-open his clinical trials
after suspension.
EMILY STOOPLER
estoopler20@gsb.columbia.edu
Strategy and Operations
Columbia University School of Social Work
New York, NY
M.S.S.W., 2012
Cornell University
Ithaca, NY
B.S., 2010
NEW YORK-PRESBYTERIAN HOSPITAL,
New York, NY
Psychiatric Social Worker
2012 – 2018
Counseled adult hospital inpatients with
acute psychiatric diagnoses.
Coordinated safe and timely discharge
plans for patients to reduce hospital
length of stay.
Presented cases in interdisciplinary
rounds with doctors and nurses.
Interfaced with insurance companies to
obtain prior authorizations for inpatient
hospital admissions.
PUTNAM FAMILY AND COMMUNITY
SERVICES, Carmel, NY
Social Work Intern
2010 – 2011
Engaged clients with severe and
persistent mental illness in treatment by
conducting home visits.
Developed long-term, client-centered
treatment plans.
JEWISH BOARD OF FAMILY AND
CHILDREN’S SERVICES, New York, NY
Social Work Intern
Summer 2011
Interviewed and evaluated
undergraduate students seeking
internships with JBFCS.
Coordinated student placements with
JBFCS agencies.
AARTI TARKAR
atarkar20@ gsb.columbia.edu
Management and Consulting
University of Connecticut, Storrs, CT Ph.D. in
Physiology and Neurobiology, 2015
MS in Cell Biology, 2009
GLAXOSMITHKLINE, COLLEGEVILLE, PA,
Investigator and Biology Manager,
Discovery Partnerships with Academia
June 2017 – Present
Structured research ideas and
experimental plans to gain insights into
pathophysiology of anemia, oncology and
immunology.
Identified novel treatment mechanism that
would help patients with iron overload
disorders.
Directed key experiments for evaluating
novel genes implicated in pancreatic
cancer and lymphomas to be therapeutic
targets.
Managed internal GSK and external
universities’ stakeholders to ensure
effective execution of program research
objectives.
Organized the 4th annual conference
for Women’s Leadership Initiative that
provides members with opportunities to
develop leadership and other skills.
Postdoctoral Scientist, Ischemic
Myocardial Injury, Heart Failure DPU
2015 – 2017
Led first-in-class initiative of big data
analysis to develop profile for pathways
altered following heart failure.
Identified mechanism of action for
candidate drug molecules for treatment
of myocardial infarction that is an unmet
medical need.
IGNACIO THOMSON
ithomson20@gsb.columbia.edu
Investment Banking
Instituto Tecnológico de Buenos Aires (ITBA)
Buenos Aires, Argentina
BSc, Industrial Engineering
GRUPO FINANCIERO GALICIA,
Buenos Aires, Argentina
Strategy Associate
2016 – 2018
Spearheaded first-ever bank spin-off in
Argentina and first follow-on offering of
GGAL ($633M) priced at all-time high
price.
Headed post-merger integration of a
20-branch bank. Synchronized activities
of IT, operations, marketing, retail
banking, HR, audit, accounting and legal
departments.
ITAU BBA, Buenos Aires, Argentina
Investment Banking Analyst
2012 – 2016
Closed 15+ M&A, ECM and DCM deals
across Argentina, Brazil, Chile, Peru,
Colombia and Ecuador, totaling $10+ bn.
Key liaison with client’s management,
leading daily interaction with cross-border
and cross-functional teams.
Performed exhaustive valuation and
modeling analysis, including multiples,
DDM, residual income, LBO, merger
consequences , sum-of-the-parts and
accretion-dilution analysis.
Tailored different valuation methods to
account for macro-distortions in LatAm
capital and money markets.
31
2020 : Woodruff - Zhao
AMY WOODRUFF
awoodruff20@gsb.columbia.edu
Finance
University of Michigan
Ann Arbor, MI
BS, Neuroscience, 2015
REGENERON PHARMACEUTICALS,
Tarrytown, NY
Research Associate
2014 - 2018
Engineered and optimized cellular studies
to test drug candidates for the Immuno-
Oncology pipeline based on biological
relevance and competitive landscape to
determine lead drug selection for clinical
trials.
Worked collaboratively across Oncology
department and led in-vitro based assay
team on diverse portfolio of 50 Immuno-
Oncology drug targets, which resulted in
advancing over 7 drugs to clinical trials and
one FDA approval for PD-1 drug molecule,
Libtayo.
Analyzed and presented lab results
to senior management; made
recommendations about which drugs to
advance.
MERRILL LYNCH PRIVATE BANKING AND
INVESTMENT GROUP, Boston, MA
Intern
2013
Led new company initiative to expand
investment portfolio to include socially
responsible investments.
Identified socially responsible companies
and initiated meetings to research
competitor product offerings of an
emerging market niche to inform Merrill
Lynch’s launch of a new product offering in
ESG investments.
32 2019-2020 HCIA RÉSUMÉ BOOK
MINGMING WU LU YE
miwu20@gsb.columbia.edu lye20@gsb.columbia.edu
Marketing and Strategy
University of Waterloo
Waterloo, Canada
BMath, Actuarial Science and Financial
Analysis, 2013
MEMORIAL SLOAN KETTERING CANCER
CENTER, New York, NY
Senior Investment Analyst
2017 – 2018
Spearheaded research in US real
estate market by presenting analysis
of investment returns relative to other
industries; resulted in team’s decision to
invest $20M in a real estate fund.
Led a cross-functional team to migrate
investment reporting processes to new
system; upgraded to enhanced reports.
Investment Analyst
2016 – 2017
Rebuilt two existing tools into automated
templates that aggregate fund returns to
quantify portfolio risk, using self-taught
VBA programming skills; improved time
spent from 2 hours to less than 10 minutes
CANADA PENSION PLAN INVESTMENT
BOARD, Toronto, Canada
($360B assets under management)
Investment Analyst
2013 – 2015
Owned domain knowledge in the US
health insurance, healthcare IT, and
hospitals industries.
Built database of national Medicare
coverage and presented insights that
showed sustainable competitive advantage
of a health insurance company, culminating
in an investment in the company that
returned 50% over 6 months.
Consulting, Investment
Research and Finance
Fordham University
New York, NY
M.S. in Quantitative Finance, 2012
Southwest University of Science
and Technology, Sichuan, China
Bachelor in Economics, 2010
DBRS, Inc., New York, NY
Assistant Vice President, Structured Finance,
2018
Senior Financial Analyst,
2016 – 2017
Financial Analyst,
2013 – 2015
Formulated credit ratings on deal team
of eight analysts for 60+ complex RMBS
transactions; rating recommendations
resulted in #1 market share of DBRS in the
largest segment in private RMBS market by
end of 2017.
Created prototype of analytical tool
to assess risks underlying prepayment
volatilities unseen in previously rated
deals, facilitating an expedited closing of a
$240MM deal issued by a top 15 fixed-
income hedge fund.
Supervised a team of three to manage
seamless execution of eight RMBS deals
across three parties by coordinating all
communications with issuer, underwriting
manager, and diligence vendor and training
clients on rating methodology.
Initiated six-month cross-training of two
Canadian analysts, facilitating assistance of
Canadian counterparts in US transactions
and cultivating interdepartmental
relationship.
Spearheaded an annual research project
on deal performance, housing market
trends and RMBS market outlook.
CARLOS ZARAZUA
czarazua20@gsb.columbia.edu
Strategy and Consulting
University of Notre Dame
Notre Dame, Indiana
BBA, Finance and Economics, 2012
VMG HEALTH, Dallas, TX
Manager – Business Valuation
2017 – 2018
Delivered minority and control level
business valuations and transaction
advisory services in the health care
services space.
Mentored and developed a team of 4
analysts and a senior analyst through
proactive goal-setting and consistent
feedback.
Managed and executed entire life-cycle
of 8-12 valuations per month from the
initial evaluation, scope, budgeting, and
resource management stage through the
end of the engagement.
Senior Analyst – Business Valuation
2015 – 2017
Led client relationships with over 15
clients annually, directing 5-10 projects
per month and training and supervising 8
individual analysts to deliver fair market
value analyses and recommendations.
Analyst – Business Valuation
2013 – 2014
Actively supported team by performing
detailed financial analysis and modeling,
due diligence, and report writing for 5-10
valuations per month.
Advised on 5-10 small and large
transactions annually regarding
commercial insurance reimbursement
by performing black-box comparison
analyses of contracted reimbursement
rates for each party and expected post-
transaction reimbursement.
Co-authored an article published in
ImagingBiz demonstrating best practices
in the valuation of imaging centers
in response to increases in imaging
reimbursement.
JOSHUA ZENILMAN
jzenilman20@gsb.columbia.edu
Strategy, Growth and Scaling
Washington University in St. Louis
St. Louis, MO
BS, Finance and International Business, 2013
CAIN BROTHERS & COMPANY,
San Francisco, CA
Associate
2016 – 2018
Advised on 15+ transactions totaling in
excess of $2.5B+ of aggregate transaction
volume.
Led junior banker coverage of multiple
subsectors (outsourced hospital services,
multi-site/retail health care, post-acute
care); drafted industry perspectives, and
tracked prospective client targets.
CAIN BROTHERS & COMPANY,
San Francisco, CA
Analyst
2013 – 2015
Acted as sole analyst on a range of buyside
and sellside M&A transactions
Received early promotion to Associate
(three-year program; notified of promotion
after 2nd year, effective after 2.5 years).
TIFFANY ZHAO
yzhao20@gsb.columbia.edu
Pharmaceuticals and Consulting
Columbia University
Fu Foundation of Engineering
MS, Biomedical Engineering, 2014
University of California, San Diego
La Jolla, CA
BS, Bioengineering, 2013
MSQ VENTURES, New York, NY
VP, Healthcare (Pre-MBA Internship)
2018
Provided strategic advice to early- to
late-stage pharma companies looking for
international partners / investors.
THE DEDHAM GROUP, New York, NY
Senior Analyst
2016 – 2017
Performed competitive landscape
assessment and optimized patient access
by enhancing patient-assistant program.
Reinvented self-dispensing model for
oral oncolytics portfolio and constructed
hospital system partnership strategies
to improve access and optimize value
proposition.
REGENERON PHARMACEUTICALS,
Tarrytown, NY
Research Associate II
2014 – 2016
Designed and executed stability studies
and implemented analytical methods to
support formulation development from
initial screening through commercialization.
33
NOTES
35
 Healthcare & Pharmaceutical Management Program
www8.gsb.columbia.edu/healthcare

Healthcare Industry Association (HCIA)

columbiahcia.com

36 2019-2020 HCIA RÉSUMÉ BOOK